Articles

Illinois House votes to lift smoking ban at casinos

Tom Swoik, executive director of Illinois Casino Gaming Association, said gambling revenue has dropped 32 percent since the state’s smoking ban was approved. He said the ban has cost state government about $800 million in taxes.

Read More

Q&A

Susan Rider is an employee-benefits account manager at Indianapolis-based Gregory & Appel Insurance. On July 1, she will become president of the Indiana State Association of Health Underwriters. She spoke about the first-year impact of the 2010 health reform law and further changes to come.

Read More

Zimmer goes on offensive against lawyers

The Warsaw-based maker of orthopedic implants has filed suit to stop a Detroit-area law firm from making allegedly false claims and using its trademarks on websites designed to attract plaintiffs to sue Zimmer over one of its knee-replacement implants called NexGen.

Read More

WellPoint gets vote of confidence

Health reform will make health insurance a less-profitable business, but WellPoint Inc. got a vote of confidence from bond analysts because health-reform rules have turned out milder than expected and WellPoint’s financial performance has been particularly strong as the economy recovers.

Read More

Hospitals’ finances improve somewhat in 2010

It was a good but not great year financially for three of the four largest hospital systems operating in the Indianapolis area last year—and hospital analysts are expecting several head winds to continue.

Read More

Self-funded plans draw small-firm interest

In the face of new health reform restrictions, expect more small employers to opt for self-funded health benefits, concludes a report this week from Indianapolis-based United Benefit Advisors.

Read More

Drugmakers call off animal-health deal, possible asset sale

Drugmakers Merck & Co. and Sanofi-Aventis SA have abandoned plans to combine their animal-health businesses after wrestling with regulators for a year over potential divestitures.
Indianapolis-based Eli Lilly and Co. was among a list of possible suitors for about $1 billion in assets the two companies considered selling.

Read More

Lechleiter: After the deluge, we’ll be fine

Eli Lilly and Co. CEO John Lechleiter visited Japan last week—three days before the massive earthquake—to deliver his tried-and-true message: Drug companies need to reinvent invention, governments needs to support innovation, and Lilly will be just fine after it has sustained the damage of the next three years.

Read More